Toronto Dominion Bank’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25
Closed -$278 1471
2024
Q1
$278 Sell
25
-59
-70% -$592 ﹤0.01% 1276
2023
Q4
$942 Buy
84
+19
+29% +$157 ﹤0.01% 1328
2023
Q3
$488 Sell
65
-8
-11% -$65 ﹤0.01% 1506
2023
Q2
$1K Sell
73
-25,327
-100% -$211K ﹤0.01% 1407
2023
Q1
$204K Buy
+25,400
New +$236K ﹤0.01% 1138
2022
Q3
Sell
-61
Closed 1599
2022
Q2
$0 Sell
61
-10
-14% -$58 ﹤0.01% 1504
2022
Q1
$0 Buy
71
+17
+31% +$86 ﹤0.01% 1599
2021
Q4
$0 Buy
54
+31
+135% +$231 ﹤0.01% 1656
2021
Q3
$0 Sell
23
-32
-58% -$240 ﹤0.01% 1405
2021
Q2
$0 Buy
55
+40
+267% +$267 ﹤0.01% 1413
2021
Q1
$0 Buy
+15
New +$113 ﹤0.01% 1488
2020
Q4
Sell
-78
Closed 1372
2020
Q3
$0 Buy
+78
New +$550 ﹤0.01% 1269
2020
Q2
Sell
-23
Closed 1277
2020
Q1
$0 Sell
23
-319
-93% -$2.08K ﹤0.01% 1304
2019
Q4
$2K Buy
342
+210
+159% +$1.13K ﹤0.01% 1276
2019
Q3
$0 Sell
132
-16
-11% -$71 ﹤0.01% 1522
2019
Q2
$0 Buy
148
+119
+410% +$504 ﹤0.01% 1558
2019
Q1
$0 Buy
29
+17
+142% +$112 ﹤0.01% 1606
2018
Q4
$0 Sell
12
-65
-84% -$454 ﹤0.01% 1542
2018
Q3
$1K Buy
77
+54
+235% +$501 ﹤0.01% 1319
2018
Q2
$0 Buy
+23
New +$273 ﹤0.01% 1477
2018
Q1
Sell
-57
Closed -$1K 1339
2017
Q4
$1K Buy
57
+51
+850% +$509 ﹤0.01% 1223
2017
Q3
$0 Buy
+6
New +$70 ﹤0.01% 1180

Other funds holding FENC

Toronto Dominion Bank's FENC Position: Q2 2024 in Review

Toronto Dominion Bank sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 25 shares — an estimated $278 sold.

Toronto Dominion Bank first reported a position in FENC in Q3 2017 and held it in 22 quarters. The position peaked at $204K in Q1 2023. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.

  • Toronto Dominion Bank reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 25 Fennec Pharmaceuticals shares in Q2 2024, an estimated $278.
  • Toronto Dominion Bank first reported a position in Fennec Pharmaceuticals in Q3 2017 and held it in 22 quarters.
  • Toronto Dominion Bank's Fennec Pharmaceuticals position peaked at $204K in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.

Based on Toronto Dominion Bank's 13F filing for Q2 2024, filed 14 Aug 2024.